Researchers are excited about Retatrutide , a novel dual agonist showing significant data in early trials for weight reduction . It works by impacting two hormones : GLP-1 and GIP, that , when activated https://teganinlo703115.articlesblogger.com/63165053/this-new-prospect-for-body-reduction